Abstract: This study explored the association between the acute psychobiological stress response, chronic social overload and amniotic fluid corticotropin corticotropin-releasing hormone (CRH) and urocortin (UCN) in 34 healthy, second-trimester pregnant women undergoing amniocentesis. The study further examined the predictive value of second-trimester amniotic fluid CRH and UCN for fetal growth and neonatal birth outcome. The amniocentesis served as a naturalistic stressor, during which maternal state anxiety and salivary cortisol was measured repeatedly and an aliquot of amniotic fluid was collected. The pregnant women additionally completed a questionnaire on chronic social overload. Fetal growth parameters were obtained at amniocentesis using fetal ultrasound biometry and at birth from medical records. The statistical analyses revealed that the acute maternal psychobiological stress response was unassociated with the amniotic fluid peptides, but that maternal chronic overload and amniotic CRH were positively correlated. Moreover, amniotic CRH was negatively associated with fetal size at amniocentesis and positively with growth in size from amniocentesis to birth. Hardly any studies have previously explored whether acute maternal psychological stress influences fetoplacental CRH or UCN levels significantly. Our findings suggest that 1) chronic, but not acute maternal stress may affect fetoplacental CRH secretion and that 2) CRH is complexly involved in fetal growth processes as previously shown in animals.
INTRODUCTION
Prenatal stress has been linked to elevated levels of placental corticotropin-releasing hormone (CRH) in the maternal blood (Hobel, Dunkel-Schetter, Roesch, Castro, & Arora, 1990 ). Yet, contradictory findings exist as well (Petraglia et al., 2001) . Both CRH and its close relative, urocortin (UCN), play prominent roles in human stress regulation and pregnancy.
CRH is released by the hypothalamus in response to stress. During pregnancy, the placenta likewise produces CRH, and placental mRNA expression in humans is detectable by seven weeks' gestation . The placenta secretes CRH predominantly into the maternal bloodstream causing maternal plasma levels to rise gradually from about 16 weeks' gestation with a more rapid increase setting in from approximately 24 and 30 weeks' gestation onwards (Campell et al., 1987; Golan, Jozak, & Conwell, 1994; Lockwood et al., 1996; McLean et al., 1995) . Placental CRH reaches the maternal pituitary and stimulates adrenocorticotropic hormone (ACTH) and cortisol production.
Cortisol, in turn, stimulates placental CRH secretion, which is contrary to the inhibitory effect it has on hypothalamic CRH . This feed-forward loop contributes to the well-known up-regulation of the maternal hypothalamic-pituitary-adrenal (HPA) axis in pregnancy.
The placenta releases small amounts of CRH into the fetal circulation, and levels in fetal plasma and amniotic fluid are measurable between 15-17 weeks' gestation (Gitau, Fisk, & Glover, 2004; Salminen-Lappalainen & Laatikainen, 1990) . Fetal CRH levels are lower than and modestly correlated with maternal levels (Gitau et al., 2004; Smith, 2007) . Studies to date have produced contradictory findings on whether fetal concentrations rise with advancing gestation. While some have not found any significant association between gestational age and fetal plasma CRH during the second half of gestation (Gitau et al., 2004; Lockwood et al., 1996) or between gestational age and amniotic CRH within the third trimester (Emanuel et al., 1994) , others have reported a significant increase in amniotic CRH from the second trimester to birth (Laatikainen, Räisänen, & Salminen, 1988) . Taken together, it is assumed that fetal CRH levels increase from early to late gestation (Smith, 2007) , but probably at a slower pace than maternal levels.
Placental CRH stimulates the fetal HPA axis, fetal cortisol secretion, organ maturation and J U S T A C C E P T E D growth (Grammatopoulos, 2008) . However, increased concentrations are linked to growth restriction (Wadhwa et al., 2004) . Moreover, placental CRH is associated with the timing of parturition. For example, maternal CRH concentrations during the early second trimester predict pre-, post-, and at term deliveries (McLean et al., 1995) . However, it recently has been postulated that rather than causing growth restriction or preterm birth, elevated CRH concentrations reflect a placental response to adverse intrauterine conditions to enhance the flow of nutrients to the fetus and accelerate growth (Gangestad, Caldwell Hooper, & Eaton, 2012) . If these heightened metabolic demands cannot be met anymore, birth onset is triggered.
UCN has biological homology to CRH and binds to CRH receptors and the CRH-binding protein (CRH-BP) (Florio, Vale, & Petraglia, 2004) . The neuronal circuits of CRH and UCN are complexly interrelated and UCN appears to play a particular important role in stress adaptation (Kozicz, 2007) . UCN is expressed in various reproductive tissues including the placenta (Florio et al., 2004) , but has received little attention in prenatal stress research.
The key roles of CRH and UCN in stress and pregnancy and their high pharmacological resemblance underline the importance of studying both peptides more in depth. One underinvestigated question in this connection is whether the acute maternal stress response affects fetoplacental CRH and/or UCN levels (Thomson, 2013) .
Amniotic CRH and UCN are of fetoplacental origin (Torricelli et al., 2009) and their levels can be determined during ongoing human pregnancy from amniotic fluid samples obtained at amniocentesis. Our workgroup has previously shown that this medical procedure elicits an anticipatory psychobiological stress response in pregnant women leading to significant higher levels of state anxiety, perceived stress, and salivary cortisol compared to a rest condition (Ghaemmaghami, Dainese, La Marca, Zimmermann, & Ehlert, 2014 ). In the current study, we therefore explored whether 1) the acute maternal psychobiological stress response and 2) chronic maternal stress are associated with amniotic CRH and/or UCN. We also examined whether 3) these peptides are related to fetal growth. We refrained from formulating a hypothesis for research question 1) due to its exploratory nature. However, based on the literature, we assumed that chronic stress would be associated with higher CRH and UCN levels. Conversely, we expected higher amniotic CRH and J U S T A C C E P T E D UCN to be linked to lower fetal size and weight at amniocentesis and birth, shorter pregnancy duration, and increased catch-up growth.
MATERIALS AND METHODS

Overview
The current study is part of a larger prospective project on the psychobiological stress response in second-trimester pregnant women and their unborn children. The project details have been summarized previously (Ghaemmaghami et al., 2014; La Marca-Ghaemmaghami, Dainese, La Marca, Zimmermann, & Ehlert, 2015) .
Participants
Healthy second-trimester pregnant women between the age of 18 and 45 years, with a singleton intrauterine pregnancy undergoing amniocentesis for karyotyping were eligible for the Healthy pregnant women who had received an appointment for a second-trimester amniocentesis were informed about the ongoing study and asked whether they were interested in participating. Exclusion criteria were clarified during a phone screening interview prior to study inclusion and involved the following parameters: artificial insemination, known maternal and fetal medical complications, suspected or known fetal growth restriction, ultrasound confirmed fetal structural anomalies, maternal psychiatric disorder, smoking or alcohol consumption of more than one glass of wine or beer per week, medication use (e.g., glucocorticoids, psychotropic drugs, diuretics, antihypertensives, and vasodilators), and food and/or protein restrictions (e.g., vegetarian or vegan diet). Additionally, the pregnant women underwent a structured clinical interview during a laboratory visit using the computerized version of the Munich Composite Diagnostic Interview (Wittchen & Pfister, 1997) for the assessment of mental disorders according to DSM-IV in order to verify the absence of a psychiatric disorder. The interviews were conducted by trained clinical psychologists.
A total of 34 healthy pregnant women were included into the final sample. However, the amniotic fluid aliquot of one woman was contaminated with blood, and thus, excluded from statistical analyses for testing hypotheses involving amniotic fluid.
All women who were included into the current study had a normal amniocentesis test result and gave birth to a healthy child.
Procedure
All amniocenteses were scheduled for the morning hours due to the various hospital proceedings and logistics. The pregnant women were instructed to abstain from heavy physical exercise, chewing gum, caffeine and alcohol intake 24 hours prior to the amniocentesis appointment and to refrain from eating two hours, and from tooth brushing one hour beforehand. The women arrived at the hospital approximately 50 minutes prior to the amniocentesis procedure itself, gave written informed consent, and responded to study administrative questionnaires. Subsequently, the pregnant women repeatedly provided saliva samples and responded to psychological state questionnaires. They were examined by ultrasound prior to the amniocentesis procedure, and gestational age was determined by fetal ultrasound biometry. After the amniocentesis intervention, the pregnant women were still monitored for another 60 minutes in order to capture the entire stress recovery phase. The women received 200 Swiss Francs for their study participation, as well as a gift set containing skincare products for pregnancy, motherhood and infant care.
The study protocol was in accordance with the declaration of Helsinki and approval by the Ethics Committees of the Canton of Zurich, Schaffhausen, and Lucerne was acquired prior to the data collection phase.
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Outcome measures
Psychological measures
Information on maternal state anxiety levels were obtained at -40 minutes and -10 minutes prior to, and then again at +20 minutes following the amniocentesis procedure by using the validated German version of the state subtest of the State-Trait Anxiety Inventory (STAI-s) (Laux, Glanzmann, Schaffner, & Spielberger, 1981; Spielberger, Gorsuch, & Lushene, 1970) . Respondents are asked to describe their current feelings (e.g., 'I am tense' or 'I feel nervous') on a four-point Likert-type scale extending from (1) not at all to (4) very much so. Cronbach's alpha for the STAI-s lies at .91 (cf., Laux et al., 1981) .
Maternal chronic social stress exposure was measured after the pregnant women had received notification of a normal amniocentesis test result by means of the social overload subscale of the Trier Inventory for Chronic Stress (TICS) (Schulz & Schlotz, 1999 ) -a widely used questionnaire to assess the experience of chronic stress. The respondents are asked to answer how often they have experienced various stressful situations in the past three months on a five-point Likert-type scale ranging from (0) never to (4) very often. The social overload subscale measures excessive demands a person takes for other people (e.g., 'I spend a lot of time dealing with other peoples' problems' or 'I have work to do that involves carrying a lot of responsibility for other people.'). The sum-scores can range from 0 (never having experienced social overload in the past three months) to 24 (having experienced social overload very often in the past three months). In a representative German sample, female participants reached a mean value of 7.8 (standard deviation = 5.1) on this subscale (Petrowski, Paul, Albani, & Brähler, 2012 ). Cronbach's alpha for this subscale ranges from .84 to .86 (Petrowski et al., 2012; Schulz, Schlotz, & Becker, 2004) .
Biochemical measures
The saliva samples were collected at -1 minute prior to and again at +10, +20, +30, +45, and +60 minutes after the amniocentesis procedure by means of Salivettes (Sarstedt, Sevelen, Switzerland). The saliva samples were immediately stored at -20 °C until biochemical analysis.
Salivary cortisol was analyzed with a highly sensitive liquid chromatography-tandem mass J U S T A C C E P T E D spectrometry (LC-MS/MS) method to overcome the problem of cross-reactivity with other similar substrates such as salivary cortisone (Perogamvros et al., 2009 ). There were three missing values due to insufficient saliva in the swabs of three different participants at the following time points: -1 minute, +10 minutes, and +20 minutes. These three missings were substituted with estimated values following Jönsson et al. (2010) by calculating the mean quotient (slope) between the missing and the subsequent values of all participants and multiplying this mean quotient with the respective pregnant woman's salivary cortisol value prior to the missing one (cf., Ghaemmaghami et al., 2014 ).
An aliquot of 2 ml of amniotic fluid was obtained for study purposes and immediately frozen at -80 °C until the biochemical analyses took place. Amniotic fluid CRH levels were analyzed with a CRH-radioimmunoassay (RIA) (cf., Stalla et al., 1989) . The lower limit of detection (LOD) was 40pg/ml. The intra-assay coefficient of variance was 6.1% and the inter-assay coefficient of variance 7.9%. Amniotic fluid UCN was analyzed using the RK-019-14 Urocortin (Human) -RIA-Kit (range: 10-1280 pg/ml) developed by Phoenix Pharmaceuticals, Inc. Karlsruhe, Germany, with a rabbit antipeptide serum. The lower LOD for amniotic fluid UCN was 20pg/ml.
Measures of fetal growth and neonatal birth outcome
Fetal size and weight were assessed at the amniocentesis procedure by means of fetal ultrasound biometry. Data regarding neonatal size and weight at birth, as well as length of gestation were obtained from medical records. We assessed fetal growth from amniocentesis to birth by subtracting fetal size and weight at the amniocentesis appointment from neonatal size and weight at birth.
Statistical Analyses
The statistical analyses were performed using SPSS (Chicago, IL, version 21) for windows.
For all analyses, values of amniotic fluid CRH and UCN below the LOD were set to LOD/√2 following recommendations for not highly skewed data by Hornung and Reed (1990) . This was the case for 11 CRH and for none of the UCN values. Subsequent analyses showed no significant differences with regard to gestational age at amniocentesis between the women with amniotic CRH The area under the curve with respect to increase (AUCi) was computed for maternal state anxiety (STAI-s) and salivary cortisol responses using a trapezoid formula as previously described by Pruessner, Kirschbaum, Meinlschmid, and Hellhammer (2003) . However, in order to take the morning decline in salivary cortisol into account, a slightly modified trapezoid formula was calculated which included subtracting the skew AUC with respect to ground (AUCg) for the connection between the first and the last salivary measures (cf., Ghaemmaghami et al., 2014) .
Potential associations between maternal psychological and biological parameters, amniotic fluid CRH and UCN measures, and fetal growth variables were explored using Kendall's tau for nonparametric data. Kendall's tau is recommended for the analyses of small data sets, as is the case in the present study, since it enables more accurate generalizations than Spearman's rho (Field, 2013) and is more robust to extreme observations (Wilcox, 2016) . In order to compare effect sizes across studies, Kendall's tau was additionally converted to Pearson's r as recommended by Walker (2003) .
Potential covariates were assessed prior to the main analyses based on bivariate correlations.
Maternal sociodemographic and pregnancy-related variables (i.e., maternal age, education, body mass index (BMI), gestational age at amniocentesis, and parity) were unassociated with CRH and UCN (p > .10 for all variables, see Figure 1 for the non-significant association between gestational age at amniocentesis and CRH ( Figure 1A ) and UCN ( Figure 1B) , respectively).
-insert Figure The level of significance was set at p < .05 for all analyses. One-sided tests were used for directional hypotheses.
RESULTS
Sample characteristics
The descriptive characteristics of the study population, including maternal sociodemographic, health-and pregnancy-related variables, amniotic fluid parameters, and measures of fetal growth and birth outcome, are presented in Table 1 .
-insert Table 1 
DISCUSSION
In our sample of second-trimester pregnant women, the acute psychobiological stress response was neither related to amniotic CRH nor UCN. However, our analyses did reveal a positive correlation between chronic maternal social overload and amniotic CRH. Additionally, we examined whether both amniotic fluid peptides were linked to fetal growth and neonatal birth outcome. The results of our analyses showed a negative association between CRH and fetal weight and size at amniocentesis. Conversely, a positive association between CRH and fetal catch-up growth in size from amniocentesis to birth was found. Contrary to our hypothesis, no significant association between either amniotic CRH or UCN and neonatal birth outcome (i.e., gestational age, weight, and size at birth) was apparent.
Whether acute maternal stress affects fetoplacental CRH or UCN levels has hardly been investigated so far (Thomson, 2013) , and our study aimed to contribute to the literature in this field.
With regard to psychological stress reactivity, our results are in line with previous findings from similar studies. For instance, neither did Glover, Bergman, Sakar, and O'Connor (2009) nor did we (Ghaemmaghami et al., 2014 ) detect a significant association between maternal state anxiety and amniotic fluid cortisol levels. As to the physiological stress response, our findings suggest that a transient activation of the maternal HPA axis may not necessarily lead to significant increases in fetoplacental CRH or UCN concentrations. This result is in accordance with Gitau et al. (2004) where it has an excitatory effect on CRH secretion . However, in the placental syncytiotrophoblast -the site of maternal-fetal exchange -11β-HSD2 inactivates a large percentage of maternal cortisol into its inert metabolite, cortisone (Benediktsson, Calder, Edwards, & Seckl, 1997) . Correspondingly, we previously found acute increases in maternal salivary cortisol to be positively correlated with amniotic cortisone (Ghaemmaghami et al., 2014) . The placental 11β-HSD2 enzyme may, thus, indirectly also inhibit inadequate placental CRH stimulation when high maternal cortisol levels enter the placenta after acute stress. Rodent studies show that acute maternal stress causes an immediate upregulation of placental 11β-HSD2 activity by 160% (Welberg, Thrivikraman, & Plotsky, 2005) . Prior chronic stress exposure, however, results in an impairment of this protective mechanism. Although it has long been uncertain whether a comparable process exits in humans, studies have recently begun to report similar findings in pregnant women (La Marca-Ghaemmaghami et al., 2015; O'Donnell et al., 2012) .
Most studies examining associations between maternal chronic stress and placental CRH, measured this peptide in maternal blood and reported inconsistent findings (Chen et al., 2010; Hobel et al., 1999; Latendresse & Ruiz, 2010; Mancuso, Dunkel Schetter, Rini, Roesch, & Hobel, 2004; Petraglia et al., 2001; Tse, Rich-Edwards, Koenen, & Wright, 2012) . The few studies that assessed amniotic CRH (Emanuel et al., 1994; Florio et al., 2008; Laatikainen et al., 1988; Menon, Arora, Hobel, & Fortunato, 2008; Salminen-Lappalainen & Laatikainen, 1990; Stalla et al., 1989; Torricelli et al., 2009) or UCN (Iavazzo et al., 2009; Imperatore et al., 2006; Torricelli et al., 2009 ) did not include any psychological stress variables. The current study, therefore, expands our knowledge and corroborates the theoretical assumption and evidence from previous investigations (Chen et al., 2010; Hobel et al., 1999; Latendresse & Ruiz, 2010; Mancuso et al., 2004; Tse et al., 2012 ) that maternal chronic stress leads to abnormal increases in fetoplacental CRH secretion. Chronically elevated
maternal cortisol is assumed to be one causal factor in this pathway. For instance, increased maternal cortisol at 15 weeks' gestation predicts elevated maternal CRH at 31 weeks (Sandman et al., 2006) .
Nevertheless, other mechanisms, such as increased maternal norepinephrine and epinephrine concentrations, which have been found to stimulate placental CRH release in vitro (Petraglia, Sutton, & Vale, 1989) , or stress-induced alterations of the maternal immune system, uteroplacental blood flow, or oxygen delivery may also contribute to excessive placental CRH secretion.
Our result of a negative association between CRH and fetal weight and size at amniocentesis is in accordance with Goland et al. (1993) and Wadhwa et al. (2004) . Both found higher CRH levels in maternal or umbilical cord blood to be linked to fetal growth restriction. However, the blood samples were obtained at later stages (i.e., at 31 weeks' gestation or directly after preterm birth) than our amniotic fluid samples were. Increased CRH levels do not seem to cause fetal growth restriction, yet conversely, growth restriction appears to reflect hostile intrauterine conditions to which the placenta responds to with greater CRH secretion in order to speed up fetal growth and secure survival (Gangestad et al., 2012) . Remarkable examples of such responses have been observed in animal species. For example, the tadpoles of the Western Spadefoot toad show elevated hypothalamic CRH concentrations when their ponds begin to evaporate (Denver, 1997) . This triggers a cascade of events that accelerates metamorphosis and enables the tadpoles to escape death. However, if CRH activity is experimentally blocked during pond desiccation, metamorphosis is halted (Denver, 1997) . Similarly, pregnant women, who are exposed to a prolonged period without food intake of more than 13 hours, exhibit higher plasma CRH levels compared to unexposed pregnant women (Hermann, Siega-Riz, Hobel, Aurora, & Dunkel-Schetter, 2001) . It is interesting to note that in humans, placental CRH complexly regulates the expression of glucose transporter proteins and thus, glucose availability for fetal growth (Gao et al., 2012) . Our finding of a positive correlation between second-trimester CRH and fetal catch-up growth is in line with these observations, contributes to the existing literature, and encourages further research along this path.
Few studies have assessed the predictive value of second-trimester amniotic CRH and UCN for pregnancy duration and preterm delivery. The lacking association between CRH and gestational age at birth in our sample is consistent with Torricelli et al. (2009) who did not discover any J U S T A C C E P T E D differences in second-trimester amniotic CRH levels between women with preterm and those with term births. Contrary to our results, the authors did observe lower UCN in women with preterm birth.
This latter finding was contradicted by Iavazzo et al. (2009) and then again confirmed by Karaer et al. (2013) . Second-trimester amniotic CRH and UCN might not yet yield reliable results regarding the timing of birth. Similarly, the predictive value of maternal plasma CRH for preterm delivery seems to reach clinical reliability only between 26-31 weeks' gestation (Sandman et al., 2006) .
The lacking associations between maternal psychological stress variables, fetal growth parameters, and UCN in the current study should not discourage further exploration of this peptide when researching the underlying biological pathways of prenatal stress. Although CRH and UCN are similar in structure, they play diverging roles and exert their actions via different pathways. For instance, placental CRH concentrations increase with advancing gestation while UCN levels seem to remain stable (Florio et al., 2004) . Furthermore, CRH has inflammatory properties and UCN antiinflammatory (Torricelli et al., 2009 ).
For obvious ethical reasons, we were unable to examine changes in amniotic CRH and UCN levels over time following acute maternal stress. Our results are based on a single sample. Therefore, we cannot exclude the possibility that a different or longer timeframe is required to detect associations between acute stress and fetoplacental CRH and UCN.
The relative high mean age of 37.2 years in the current sample is common for pregnant women undergoing amniocentesis. However, this circumstance reduces the generalizability of the findings to younger pregnant women.
Despite the prospective study design, our analyses are correlative and cannot not imply causality. Additional assessment of CRH and UCN in maternal blood would have also been preferable, since the relationship between the peptides in plasma and amniotic fluid is poorly understood. Moreover, larger samples are desirable when replicating our results.
We assessed maternal chronic stress relying on the social overload scale of the TICS, which measures the psychological stress experienced in the past three months. Future studies would benefit from additionally examining indicators of maternal chronic stress from a biological perspective, such as analyzing cortisol concentrations in maternal hair or nail samples. Another issue concerns the relatively high LOD of UCN and CRH. However, in many studies investigating the second-trimester (e.g., Salminen-Lappalainen & Laatikainen, 1990; Torricelli et al., 2009) , it is unclear whether the values below these specific LODs were included into the statistical analyses or not, and, if so, which methodical approach was selected. Such information needs to be documented more clearly, because diverging approaches could add to the unwanted variety in the reported peptide levels. In this study, the positive association between chronic social overload and amniotic CRH remained significant even when the samples under the LOD were excluded from the analyses. These same was true for the association between CRH and fetal catch-up growth in size from amniocentesis to birth.
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Despite these limitations, the present findings substantially advance our understanding of the biological pathways of prenatal stress and suggest that chronic, but not acute maternal stress affects fetoplacental CRH. The current results also confirm recent assumptions that CRH plays a complex and dynamic role in the mechanisms of fetal growth.
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